|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||
| Net loss | |||||
| Stock-based compensation | |||||
| Depreciation expense | |||||
| Changes in operating assets and liabilities: | |||||
| Increase in accounts receivable | |||||
| Decrease (Increase) in accounts receivable - related party | |||||
| (Increase) decrease in prepaid expenses | |||||
| Accounts payable | |||||
| Increase in accounts payable and accrued liabilities | |||||
| Increase (Decrease) in accrued interest payable-related party | |||||
| Increase (Decrease) in deposits | |||||
| Increase in payroll taxes payable | |||||
| Net cash used in operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||
| Capitalization of research and development costs | |||||
| Increase in restricted deposit | |||||
| Purchase of property and equipment | |||||
| Net cash used in investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||
| Proceeds from sale of Class A common stock | |||||
| Increase in advance payable – related party | |||||
| Proceeds from subscription receivable | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of the year | |||||
| Cash and cash equivalents, end of the year | |||||
| Supplemental disclosures for cash flow information: | |||||
| Cash paid during the year for interest | |||||
| Shares issued for conversion of debt – related party | |||||
| Non-cash transactions: | |||||
| Suppliers paid through advance payable - related party | |||||
Loading...
